4701 - 4725 of 6171 Results
Title
Year
- Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson’s Disease2017OPENTitle: Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson’s DiseaseJournal Name: Brain SciencesPublisher: MDPI AGVol: 7Issue #: 7Start Page: 74End Page: 74Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci7070074Best OA location URL: https://www.mdpi.com/2076-3425/7/7/74/pdf?version=1500945204Citation Count: 18
-
OPENTitle: Latent Cognitive Phenotypes in De Novo Parkinson’s Disease: A Person-Centered ApproachJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 23Issue #: 7Start Page: 551End Page: 563Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617717000406Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6435330Citation Count: 9
- Dopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson’s disease2017OPENTitle: Dopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-017-04254-yBest OA location URL: https://www.nature.com/articles/s41598-017-04254-y.pdfCitation Count: 25
-
OPENTitle: Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestryJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 10Start Page: 1432End Page: 1438Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27059Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5656509Citation Count: 147
- An Observational Study of the Effect of Levodopa–Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson’s Disease Patients2017OPENTitle: An Observational Study of the Effect of Levodopa–Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson’s Disease PatientsJournal Name: Advances in TherapyPublisher: Springer Science and Business Media LLCVol: 34Issue #: 7Start Page: 1741End Page: 1752Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12325-017-0571-2Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs12325-017-0571-2.pdfCitation Count: 26
-
OPENTitle: Changes in kynurenine pathway metabolism in Parkinson patients with L‐DOPA‐induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 142Issue #: 5Start Page: 756End Page: 766Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.14104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14104Citation Count: 100
- Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts2017OPENTitle: Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohortsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 16Issue #: 8Start Page: 620End Page: 629Publication Date:Open Access(OA) Status: OPENLicense: other-oa, publisher-specific-oaDOI - Digital Object Identifier: 10.1016/s1474-4422(17)30122-9Best OA location URL: https://doi.org/10.1016/s1474-4422(17)30122-9Citation Count: 167
-
OPENTitle: Neuropathologic features of TOMM40 '523 variant on late‐life cognitive declineJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 13Issue #: 12Start Page: 1380End Page: 1388Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2017.05.002Best OA location URL: http://doi.org/10.1016/j.jalz.2017.05.002Citation Count: 23
- Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates2017OPENTitle: Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primatesJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1186/s40478-017-0451-7Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0451-7Citation Count: 40
- Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons2017OPENTitle: Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal PersonsJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 317Issue #: 22Start Page: 2305End Page: 2305Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2017.6669Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2631529/jama_donohue_2017_oi_170051.pdfCitation Count: 385
- Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study2017OPENTitle: Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation studyJournal Name: PLOS MedicinePublisher: Public Library of Science (PLoS)Vol: 14Issue #: 6Start Page: e1002314End Page: e1002314Publication Date:Open Access(OA) Status: OPENLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pmed.1002314Best OA location URL: https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1002314&type=printableCitation Count: 167
-
OPENTitle: A Bayesian mathematical model of motor and cognitive outcomes in Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 6Start Page: e0178982End Page: e0178982Publication Date:Open Access(OA) Status: OPENLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0178982Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0178982&type=printableCitation Count: 14
-
OPENTitle: Mild cognitive impairment as a risk factor for Parkinson's disease dementiaJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 7Start Page: 1056End Page: 1065Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27002Best OA location URL: https://www.repository.cam.ac.uk/handle/1810/264547Citation Count: 138
- Use of a self-rating scale of the nature and severity of symptoms in Parkinson’s Disease (PRO-PD): Correlation with quality of life and existing scales of disease severity2017OPENTitle: Use of a self-rating scale of the nature and severity of symptoms in Parkinson’s Disease (PRO-PD): Correlation with quality of life and existing scales of disease severityJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-017-0021-5Best OA location URL: https://www.nature.com/articles/s41531-017-0021-5.pdfCitation Count: 40
- Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology2017OPENTitle: Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathologyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 7Start Page: 466End Page: 477Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.421Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.421Citation Count: 37
-
OPENTitle: Connectivity Predicts deep brain stimulation outcome in Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 82Issue #: 1Start Page: 67End Page: 78Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24974Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5880678Citation Count: 609
-
OPENTitle: A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-SynucleinJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 14Issue #: 4Start Page: 1107End Page: 1119Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1007/s13311-017-0544-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-017-0544-9.pdfCitation Count: 53
-
OPENTitle: Role of LRRK2 in the regulation of dopamine receptor traffickingJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 6Start Page: e0179082End Page: e0179082Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0179082Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0179082&type=printableCitation Count: 67
-
OPENTitle: Cutaneous Alpha-Synuclein From Paraffin Embedded Autopsy Specimens in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 7Issue #: 3Start Page: 503End Page: 509Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-171088Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5909847Citation Count: 19
-
OPENTitle: Dorsal Raphe Dopamine Neurons Modulate Arousal and Promote Wakefulness by Salient StimuliJournal Name: NeuronPublisher: Elsevier BVVol: 94Issue #: 6Start Page: 1205End Page: 1219.e8Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2017.05.020Best OA location URL: http://www.cell.com/article/S0896627317304580/pdfCitation Count: 249
-
OPENTitle: Rare Copy Number Variants in NRXN1 and CNTN6 Increase Risk for Tourette SyndromeJournal Name: NeuronPublisher: Elsevier BVVol: 94Issue #: 6Start Page: 1101End Page: 1111.e7Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2017.06.010Best OA location URL: http://www.cell.com/article/S0896627317305081/pdfCitation Count: 162
- Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling2017OPENTitle: Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and ModelingJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 123Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/55609Best OA location URL: https://europepmc.org/articles/pmc5608180?pdf=renderCitation Count: 38
-
OPENTitle: Heritability of hippocampal subfield volumes using a twin and non-twin siblings designJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 9Start Page: 4337End Page: 4352Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23654Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23654Citation Count: 28
- α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration2017OPENTitle: α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic NeurodegenerationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 105Issue #:Start Page: 84End Page: 98Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.05.014Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5701756Citation Count: 154
- 4R-Cembranoid Improves Outcomes after 6-Hydroxydopamine Challenge in Both In vitro and In vivo Models of Parkinson's Disease2017OPENTitle: 4R-Cembranoid Improves Outcomes after 6-Hydroxydopamine Challenge in Both In vitro and In vivo Models of Parkinson's DiseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2017.00272Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2017.00272/pdfCitation Count: 19